Effect of Neutrophil Priming on Chemotaxis and Signaling
Effect of Neutrophil Priming on Chemotaxis and Signaling
批准号:
7367384
负责人:
Jonathan S Reichner
金额:
$6.87万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-05-01 至 2007-05-07
关键词:
1-Phosphatidylinositol 4-KinaseAffectAnimal ModelAntigen-Antibody ComplexBindingBinding SitesBiological AssayBiological Response ModifiersBlood CirculationCD11 AntigensCD14 AntigenCD14 geneCandida albicansCandidiasisCell WallCell membraneCell physiologyCellsChemotactic FactorsChemotaxisComplexDiseaseDisseminated candidiasisDissociationDown-RegulationExtracellular MatrixFCGR3B geneFamilyFibronectinsGlucansGlycosylphosphatidylinositolsGoalsGram-Negative BacteriaHost DefenseHumanIL8 geneImmune systemImmunocompromised HostIn VitroInfectionInflammationInflammatoryInflammatory ResponseInjuryIntegrinsInvestigationLaboratoriesLaboratory FindingLeukocyte Adhesion DeficiencyLeukocytesLifeLigand BindingLigandsLinkMAP Kinase GeneMAPK14 geneMacrophage-1 AntigenMediatingMediator of activation proteinMembraneModelingMovementMycosesNosocomial InfectionsNumbersOperative Surgical ProceduresOutcomePLAUR genePathway interactionsPatientsPhosphorylationPhosphotransferasesPlayRangeRecurrenceRegulationRiskRoleSepsisSerumSignal PathwaySignal TransductionSignal Transduction PathwaySiteSourceTestingTherapeuticTissuesTransducersTraumaUp-RegulationUrokinaseUrokinase Plasminogen Activator ReceptorWorkYeastsbasecell motilitycell typefungushuman ITGA5 proteinin vivomacrophagemigrationneutrophilnovelp38 MAPK Signaling Pathwayprotein kinase C zetareceptorresearch studyresponseresponse to injurywound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Polymorphonuclear leukocytes (PMN) are an inherently motile cell type which can be directed to move up a
chemoattractant gradient. Chemotactic movement is essential for PMN accumulation at sites of tissue injury
or infection, however, mechanisms which provide the navigational signals needed to give direction to these
cells are incompletely understood. Candida albicans is the fourth leading cause of nosocomial infections with
post-surgical, trauma and immunosuppressed patients being at highest risk. I_-glucan, a major component of
the yeast cell wall, is elaborated into the bloodstream of patients with systemiccandidiasis although the role of
I_-glucan in the pathobiology of the disease is not clear. Recent findings from this laboratory have shown I_-
glucan, converts PMN migration from random to directed. The conversion is mediated by recognition of 13-
glucan by the leukocyte 132integrin CR3 (CD11 b/CD18) and is a previously unrecognized effect of 13-glucan on
neutrophil function. The long term goal of our work is to understand how host defenses are affected by 13-
glucan during the course of systemic fungal infections. The focus of the current proposal is to determine the
mechanisms through which 13-glucan recognition by CR3 alters neutrophil function. Experiments in Aim I will
investigate the role of several intracellular signalling pathways that, based on our current findings, are
hypothesized to mediate the increased chemotactic capacity of neutrophils migrating on 13-glucan-
supplemented matrix. Specific Aim II will apply a well-characterized wound model to demonstrate the effect of
_-glucan on the ability of the host neutrophils to respond to injury. In vitro findings have determined that
activation of CR3 by _-glucan regulates the function of integrins of the 131 family. The wound model will
determine whether 13-glucan and/or systemic candidiasis similarly alters the function of 131 integrins in
mediating PMN entry into a site of injury. Finally, several proinflammatory mediators (LPS, immune
complexes, urokinase plasminogen activator) bind to glycosylphosphatidylinositol (GPI)-Iinked receptors
(CD14, CD16, CD87) which in turn rely on CR3 for intracellular signalling. Specific Aim III will test the
hypothesis that a novel pathway of _1 integrin crosstalk dissociates GPl-linked receptors from CR3 molecules.
Since 13-glucan and GPl-linked receptors share a common CR3 binding site, dissociation of GPl-linked
receptor from CR3 would simultaneously increase the number of CR3 molecules available for 13-glucan binding
and blunt the response to ligands specific for GPl-linked receptors. The proposed studies will further elucidate
the mechanism of action through which I_-glucan primes neutrophils both as a component of systemic fungal
infections and as a biological response modifier with therapeutic potential for treating polymicrobial sepsis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigating the Ability of Human Blood Neutrophils to Kill Cancer
-
批准号:10648774
-
项目类别:
-
资助金额:$8.2万
-
财政年份:2023
-
负责人:Jonathan S Reichner
-
依托单位:
55th Annual Meeting of the Society for Leukocyte Biology
-
批准号:10540463
-
项目类别:
-
资助金额:$1.88万
-
财政年份:2022
-
负责人:Jonathan S Reichner
-
依托单位:
54th Annual Meeting of the Society For Leukocyte Biology
-
批准号:10318756
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2021
-
负责人:Jonathan S Reichner
-
依托单位:
Neutrophil Migration in Three Dimensions
-
批准号:8500188
-
项目类别:
-
资助金额:$18.15万
-
财政年份:2012
-
负责人:Jonathan S Reichner
-
依托单位:
Neutrophil Migration in Three Dimensions
-
批准号:8355453
-
项目类别:
-
资助金额:$24.76万
-
财政年份:2012
-
负责人:Jonathan S Reichner
-
依托单位:
Effect of Neutrophil Priming on Chemotaxis and Signaling
-
批准号:7847286
-
项目类别:
-
资助金额:$24.71万
-
财政年份:2009
-
负责人:Jonathan S Reichner
-
依托单位:
Neutrophil Mechanosensing
-
批准号:7512375
-
项目类别:
-
资助金额:$24.01万
-
财政年份:2008
-
负责人:Jonathan S Reichner
-
依托单位:
Neutrophil Mechanosensing
-
批准号:7634502
-
项目类别:
-
资助金额:$18.72万
-
财政年份:2008
-
负责人:Jonathan S Reichner
-
依托单位:
Effect of Neutrophil Priming on Chemotaxis and Signaling
-
批准号:6739082
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2003
-
负责人:Jonathan S Reichner
-
依托单位:
Effect of Neutrophil Priming on Chemotaxis and Signaling
-
批准号:7525773
-
项目类别:
-
资助金额:$29.27万
-
财政年份:2003
-
负责人:Jonathan S Reichner
-
依托单位:
Effect of Neutrophil Priming on Chemotaxis and Signaling
-
批准号:6891319
-
项目类别:
-
资助金额:$21.12万
-
财政年份:2003
-
负责人:Jonathan S Reichner
-
依托单位:
Effect of Neutrophil Priming on Chemotaxis and Signaling
-
批准号:8068691
-
项目类别:
-
资助金额:$30.29万
-
财政年份:2003
-
负责人:Jonathan S Reichner
-
依托单位:
Effect of Neutrophil Priming on Chemotaxis and Signaling
-
批准号:7067540
-
项目类别:
-
资助金额:$20.62万
-
财政年份:2003
-
负责人:Jonathan S Reichner
-
依托单位:
Effect of Neutrophil Priming on Chemotaxis and Signaling
-
批准号:7642284
-
项目类别:
-
资助金额:$30.85万
-
财政年份:2003
-
负责人:Jonathan S Reichner
-
依托单位:
Effect of Neutrophil Priming on Chemotaxis and Signaling
-
批准号:6617060
-
项目类别:
-
资助金额:$23.38万
-
财政年份:2003
-
负责人:Jonathan S Reichner
-
依托单位:
Effect of Neutrophil Priming on Chemotaxis and Signaling
-
批准号:7417341
-
项目类别:
-
资助金额:$25.45万
-
财政年份:2002
-
负责人:Jonathan S Reichner
-
依托单位:
BETA-GLUCAN RECEPTOR
-
批准号:2392214
-
项目类别:
-
资助金额:$16.59万
-
财政年份:1996
-
负责人:Jonathan S Reichner
-
依托单位:
BETA-GLUCAN RECEPTOR
-
批准号:2900822
-
项目类别:
-
资助金额:$17.89万
-
财政年份:1996
-
负责人:Jonathan S Reichner
-
依托单位:
BETA-GLUCAN RECEPTOR
-
批准号:2685040
-
项目类别:
-
资助金额:$17.23万
-
财政年份:1996
-
负责人:Jonathan S Reichner
-
依托单位:
BETA-GLUCAN RECEPTOR
-
批准号:2190063
-
项目类别:
-
资助金额:$15.46万
-
财政年份:1996
-
负责人:Jonathan S Reichner
-
依托单位:
海外基金